Mitaclau (Desmopressin)

Desmopressin, the active ingredient in Mitaclau, is a vasopressin analog presented as a sublingual formulation for sublingual use. It is employed to manage conditions such as central diabetes insipidus, nocturnal enuresis, and certain bleeding disorders by enhancing water reabsorption and raising plasma levels of clotting factors.

GNH USA supplies Mitaclau as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution across multiple regions.

Desmopressin acts on the antidiuretic hormone pathway and is used for the following indications: - Central diabetes insipidus: reduces excessive urine output and restores water balance. - Nocturnal enuresis: decreases nighttime bedwetting episodes in children and adolescents. - Hemophilia A: raises plasma factor VIII levels to improve clotting. - von Willebrand disease: increases von Willebrand factor to reduce bleeding.

Desmopressin may cause a range of adverse reactions. Common Side Effects: - Headache: mild to moderate intensity. - Nausea or abdominal discomfort. - Mild hyponatremia: slight reduction in serum sodium without severe symptoms. - Nasal irritation (if formulation contacts nasal mucosa). - Flushing or warmth sensation. Serious or Rare Side Effects: - Severe hyponatremia leading to seizures or coma. - Water intoxication with cerebral edema. - Allergic reactions such as rash, urticaria, or anaphylaxis. - Thrombotic events in patients with high factor VIII levels. - Significant hypotension or cardiovascular instability.

When prescribing Mitaclau, consider the following precautions: - Monitor serum sodium: check electrolytes regularly, especially in the first days of therapy. - Limit fluid intake: advise patients to avoid excessive water consumption while on treatment. - Use caution in renal impairment: adjust dose or increase monitoring as needed. - Adjust dose in elderly patients: increased sensitivity to antidiuretic effects may occur. - Contraindicated in known hypersensitivity to desmopressin or any excipients. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Desmopressin can interact with several medicines. Major Interactions (Avoid): - Carbamazepine: induces hepatic metabolism, reducing desmopressin efficacy. - Concomitant diuretics (especially thiazides): increase risk of hyponatremia. - Vasopressin antagonists (e.g., conivaptan): oppose therapeutic action. Moderate Interactions (Monitor Closely): - NSAIDs: may blunt renal response to desmopressin. - ACE inhibitors or ARBs: can potentiate antidiuretic effect and hyponatremia. - SSRIs or SNRIs: additive risk of low sodium levels. - Anticoagulants: monitor clotting parameters when used for bleeding disorders.